Cargando…
Adjunctive Probiotic Lactobacillus rhamnosus Probio-M9 Administration Enhances the Effect of Anti-PD-1 Antitumor Therapy via Restoring Antibiotic-Disrupted Gut Microbiota
Emerging evidence supports that the efficacy of immune checkpoint blockade (ICB) therapy is associated with the host’s gut microbiota, as prior antibiotic intake often leads to poor outcome and low responsiveness toward ICB treatment. Therefore, we hypothesized that the efficacy of ICB therapy like...
Autores principales: | Gao, Guangqi, Ma, Teng, Zhang, Tao, Jin, Hao, Li, Yalin, Kwok, Lai-Yu, Zhang, Heping, Sun, Zhihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712698/ https://www.ncbi.nlm.nih.gov/pubmed/34970262 http://dx.doi.org/10.3389/fimmu.2021.772532 |
Ejemplares similares
-
Change in the Gut Microbiome and Immunity by Lacticaseibacillus
rhamnosus Probio-M9
por: Zhang, Meng, et al.
Publicado: (2023) -
Lacticaseibacillus rhamnosus Probio-M9 extends the lifespan of Caenorhabditis elegans
por: Zhang, Juntao, et al.
Publicado: (2022) -
Inhibitory Effects of Breast Milk-Derived Lactobacillus rhamnosus Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model
por: Xu, Haiyan, et al.
Publicado: (2021) -
Lacticaseibacillus rhamnosus Probio-M9-Driven Mouse Mammary Tumor-Inhibitory Effect Is Accompanied by Modulation of Host Gut Microbiota, Immunity, and Serum Metabolome
por: Zhang, Weiqin, et al.
Publicado: (2022) -
Lactobacillus rhamnosus Probio-M9 Improves the Quality of Life in Stressed Adults by Gut Microbiota
por: Zheng, Yan, et al.
Publicado: (2021)